gallic acid has been researched along with ketamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geiger, JD; Haughey, NJ; Holden, CP; Nath, A | 1 |
| Kudoh, A; Matsuki, A | 1 |
| Dhingra, MS; Dhingra, S; Jindal, DK; Kumar, A; Parle, M; Yadav, M | 1 |
| Baccin, PS; Burger, ME; Mangini, LT; Martins, LR; Milanesi, LH; Rosa, HZ; Schimites, PI; Segat, HJ; Soares, AV; Teixeira, LG | 1 |
| Brum, GF; Burger, ME; Metz, VG; Milanesi, LH; Rosa, HZ; Rosa, JLO; Rossato, DR | 1 |
5 other study(ies) available for gallic acid and ketamine
| Article | Year |
|---|---|
Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat.
Topics: 2-Amino-5-phosphonovalerate; Astrocytes; Brain; Calcium; Calcium Channel Blockers; Cell Death; Cells, Cultured; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino Acid Antagonists; Fetus; Gallic Acid; Gene Products, tat; HIV-1; Humans; Inositol 1,4,5-Trisphosphate; Ketamine; Neurons; Neurotoxins; Pertussis Toxin; Quinoxalines; tat Gene Products, Human Immunodeficiency Virus; Thapsigargin; Video Recording; Virulence Factors, Bordetella | 1999 |
Ketamine inhibits inositol 1,4,5-trisphosphate production depending on the extracellular Ca2+ concentration in neonatal rat cardiomyocytes.
Topics: Anesthetics, Dissociative; Animals; Bradykinin; Calcimycin; Calcium; Calcium Channel Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Space; Gallic Acid; Inositol 1,4,5-Trisphosphate; Ketamine; Myocardial Contraction; Myocardium; Rats | 1999 |
Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations.
Topics: Animals; Antioxidants; Behavior, Animal; Brain; Disease Models, Animal; Female; Gallic Acid; gamma-Aminobutyric Acid; Glutathione; Ketamine; Lipid Peroxidation; Male; Mice; Motor Activity; Protective Agents; Psychotic Disorders; Tumor Necrosis Factor-alpha | 2018 |
Gallic acid prevents ketamine-induced oxidative damages in brain regions and liver of rats.
Topics: Anesthetics, Dissociative; Animals; Brain; Cerebral Cortex; Gallic Acid; Hippocampus; Ketamine; Lipid Peroxidation; Liver; Male; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Reactive Oxygen Species; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances | 2020 |
Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.
Topics: Anesthetics, Dissociative; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Catalase; Gallic Acid; Hippocampus; Ketamine; Kidney; Lipid Peroxidation; Liver; Male; Memory; Memory Disorders; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats; Receptor, trkB; Receptors, N-Methyl-D-Aspartate | 2020 |